Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HLT | Common Stock | Options Exercise | $977K | +21.5K | +0.85% | $45.46 | 2.56M | Feb 8, 2024 | Direct | |
transaction | HLT | Common Stock | Sale | -$2.96M | -15.1K | -0.59% | $195.42 | 2.54M | Feb 8, 2024 | Direct | F1, F2 |
transaction | HLT | Common Stock | Sale | -$1.24M | -6.34K | -0.25% | $196.31 | 2.54M | Feb 8, 2024 | Direct | F1, F3 |
transaction | HLT | Common Stock | Options Exercise | $2.43M | +53.5K | +2.11% | $45.46 | 2.59M | Feb 9, 2024 | Direct | |
transaction | HLT | Common Stock | Sale | -$4.16M | -21.6K | -0.83% | $192.82 | 2.57M | Feb 9, 2024 | Direct | F1, F4 |
transaction | HLT | Common Stock | Sale | -$96.8K | -500 | -0.02% | $193.51 | 2.57M | Feb 9, 2024 | Direct | F1, F5 |
holding | HLT | Common Stock | 802K | Feb 8, 2024 | See Footnote | F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HLT | Employee Stock Option (right to buy) | Options Exercise | $0 | -21.5K | -28.66% | $0.00 | 53.5K | Feb 8, 2024 | Common Stock | 21.5K | $45.46 | Direct | F7 |
transaction | HLT | Employee Stock Option (right to buy) | Options Exercise | $0 | -53.5K | -100% | $0.00* | 0 | Feb 9, 2024 | Common Stock | 53.5K | $45.46 | Direct | F7 |
Id | Content |
---|---|
F1 | Shares sold to cover payment of option exercise price and payment of tax liability incident to exercise of option granted in February 2014 that expires on February 19, 2024. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $195.00 to $195.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $196.06 to $196.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $192.26 to $193.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $193.28 to $193.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
F6 | These shares of common stock are held by Harwood Road LLC, a limited liability company. A revocable living trust, of which Mr. Nassetta is the trustee and a beneficiary, serves as the managing member of Harwood Road LLC. 99% of the economic interests in the limited liability company are held by a family trust for the benefit of Mr. Nassetta's children and the remaining 1% is held by the aforementioned living trust. The Reporting Person states that this filing shall not be deemed to be an admission that the Reporting Person is the beneficial owner of any securities reported herein as indirectly held, and disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. |
F7 | The option vested in three equal annual installments beginning on February 19, 2015. |
President and Chief Executive Officer